<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05014113</url>
  </required_header>
  <id_info>
    <org_study_id>H-28</org_study_id>
    <nct_id>NCT05014113</nct_id>
  </id_info>
  <brief_title>H-28 DELTA ST-C and Minima Retrospective Study.</brief_title>
  <official_title>A Retrospective Study Evaluating Clinical and Radiographic Early Outcomes of Total Hip Arthroplasty With DELTA ST-C Cup and MINIMA Stem.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Limacorporate S.p.a</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Limacorporate S.p.a</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to assess the clinical and radiographic outcomes of DELTA ST-C in combination&#xD;
      with MINIMA stem at 3 years after primary THA surgery, and to evaluate the overall&#xD;
      survivorship of the implant.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Harris Hip Score (HHS)</measure>
    <time_frame>Pre-operative - Month 36</time_frame>
    <description>Assessment of Harris Hip Score from pre-operative baseline up to 3 years after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stability assessment of DELTA ST-C cup</measure>
    <time_frame>At discharge - Month 36</time_frame>
    <description>Radiographic analysis and stability assessment of the DELTA ST-C cup as rate of symptomatic radiolucent lines, loosening, and subsidence ≥ 2 mm from discharge (baseline) up to 3-year follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stability assessment of MINIMA stem</measure>
    <time_frame>At discharge - Month 36</time_frame>
    <description>Radiographic analysis and stability assessment of the MINIMA stem as rate of symptomatic radiolucent lines, loosening, and subsidence ≥ 2 mm from discharge (baseline) up to 3-year follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival rate of the implant</measure>
    <time_frame>Month 36</time_frame>
    <description>The survival rate of the implant is expressed by Kaplan-Meier estimator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety assessment (adverse events)</measure>
    <time_frame>Intra-operative - Month 36</time_frame>
    <description>Assessment of any possible adverse device event or device-related complication detected and recorded</description>
  </secondary_outcome>
  <enrollment type="Anticipated">95</enrollment>
  <condition>Osteoarthritis, Hip</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DELTA-ST cup in combination with MINIMA stem</intervention_name>
    <description>Advance articular destruction generated by primary degenerative or post-traumatic arthrosis or reumatoid arthritis; fracture or avascular necrosis; congenital or acquired deformity.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists of 95 consecutive patients who underwent to a THA with DELTA&#xD;
        ST-C cup in combination with MINIMA stem in 2017 onwards at the Psychiko Clinic and are&#xD;
        compliant with all the Inclusion and Exclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Underwent to a THA with DELTA ST-C cup and MINIMA stem in 2017 onwards&#xD;
&#xD;
          -  Both genders&#xD;
&#xD;
          -  Any race&#xD;
&#xD;
          -  A diagnosis in the target hip of one or more of the following:&#xD;
&#xD;
               1. Non-inflammatory degenerative joint disease such as osteoarthritis, avascular&#xD;
                  necrosis&#xD;
&#xD;
               2. Rheumatoid Arthritis&#xD;
&#xD;
               3. Post-traumatic arthritis&#xD;
&#xD;
               4. Fractures of femoral neck&#xD;
&#xD;
               5. Congenital or acquired deformity&#xD;
&#xD;
          -  Patient willingness to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Local or systemic infection&#xD;
&#xD;
          -  Septicaemia&#xD;
&#xD;
          -  Persistent acute or chronic osteomyelitis&#xD;
&#xD;
          -  Confirmed nerve or muscle lesion compromising hip joint function&#xD;
&#xD;
          -  Vascular or nerve diseases affecting the concerned limb&#xD;
&#xD;
          -  Poor bone stock (for example due to osteoporosis) compromising the stability of the&#xD;
             implant&#xD;
&#xD;
          -  Metabolic disorders which may impair fixation and stability of the implant&#xD;
&#xD;
          -  Any concomitant disease and dependence that might affect the implanted prosthesis&#xD;
&#xD;
          -  Metal hypersensitivity to implant materials&#xD;
&#xD;
          -  Required revision of previous standard femoral stem&#xD;
&#xD;
          -  Age &lt; 18 years old&#xD;
&#xD;
          -  Any clinically significant pathology based on clinical history that the Investigator&#xD;
             feels may affect the study evaluation including, but not limited to:&#xD;
&#xD;
               1. significant neurological or musculoskeletal disorders or disease that may&#xD;
                  adversely affect gait and compromise functional recovery&#xD;
&#xD;
               2. neuromuscular or neurosensory deficit which would limit the ability to assess the&#xD;
                  performance of the device&#xD;
&#xD;
               3. known metabolic disorders leading to progressive bone deterioration&#xD;
&#xD;
          -  Hip replacement on the contralateral side performed within less than one year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabiana Pavan</last_name>
    <phone>+393485816391</phone>
    <email>fabiana.pavan@limacorporate.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Federica Azzimonti</last_name>
    <phone>+393775450940</phone>
    <email>federica.azzimonti@limacorporate.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Psychiko Clinic (Athens Medical Group)</name>
      <address>
        <city>Athens</city>
        <state>Psychiko</state>
        <zip>115 25</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angeliki Syrigou</last_name>
    </contact>
    <investigator>
      <last_name>Nikolaos Christodoulou</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karatzas Voutsas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanouil Volonakis</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 9, 2021</study_first_submitted>
  <study_first_submitted_qc>August 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 19, 2021</last_update_submitted>
  <last_update_submitted_qc>August 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis, Hip</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

